Literature DB >> 31437680

Prevalence and characterization of methicillin-resistant Staphylococcus pseudintermedius from symptomatic companion animals in Northern Italy: Clonal diversity and novel sequence types.

Maria Luisa Menandro1, Giorgia Dotto2, Alessandra Mondin3, Marco Martini4, Letizia Ceglie5, Daniela Pasotto6.   

Abstract

The aim of this study was to assess the prevalence, the genotypic diversity, the antimicrobial resistance traits of canine and feline clinical methicillin-resistant Staphylococcus pseudintermedius (MRSP) isolates in a diagnostic laboratory in Italy during 2015-2016. All isolates were characterized by multilocus sequence typing (MLST), staphylococcal cassette chromosome (SCC)-mec typing and staphylococcal protein A (spa)-typing. The resistance profiles were assessed by antimicrobial susceptibility testing and confirmed genotypically by the detection of mecA gene and by microarray analyses. The prevalence of MRSP isolates was high (31.6%). All the strains were multidrug resistant and the most frequent clone was ST71-SCCmec type II-III. These results confirm a high prevalence of MRSP amongst clinical samples from pets in Italy. These isolates show multidrug resistance features that are of concern both in veterinary and human medicine for clinical and epidemiological reasons.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial-resistance; Cat; Dog; Methicillin-resistant Staphylococcus pseudintermedius; Microarray; Multilocus sequence typing

Mesh:

Substances:

Year:  2019        PMID: 31437680     DOI: 10.1016/j.cimid.2019.101331

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  7 in total

1.  Clindamycin resistance of skin derived Staphylococcus pseudintermedius is higher in dogs with a history of antimicrobial therapy.

Authors:  Catharina M M van Damme; Els M Broens; Silvia T Auxilia; Yvette M Schlotter
Journal:  Vet Dermatol       Date:  2020-04-22       Impact factor: 1.589

2.  Clonal Diversity and Antimicrobial Resistance of Methicillin-Resistant Staphylococcus pseudintermedius Isolated from Canine Pyoderma.

Authors:  Vanessa Silva; Ana Oliveira; Vera Manageiro; Manuela Caniça; Diogo Contente; Rosa Capita; Carlos Alonso-Calleja; Isabel Carvalho; José L Capelo; Gilberto Igrejas; Patrícia Poeta
Journal:  Microorganisms       Date:  2021-02-25

3.  From canines to humans: Clinical importance of Staphylococcus pseudintermedius.

Authors:  Karen C Carroll; Carey-Ann D Burnham; Lars F Westblade
Journal:  PLoS Pathog       Date:  2021-12-02       Impact factor: 6.823

4.  Patterns of antimicrobial, multidrug and methicillin resistance among Staphylococcus spp. isolated from canine specimens submitted to a diagnostic laboratory in Tennessee, USA: a descriptive study.

Authors:  Jennifer Lord; Nick Millis; Rebekah Duckett Jones; Brian Johnson; Stephen A Kania; Agricola Odoi
Journal:  BMC Vet Res       Date:  2022-03-08       Impact factor: 2.741

5.  Antimicrobial Activity of the Iron-Chelator, DIBI, against Multidrug-Resistant Canine Methicillin-Susceptible Staphylococcus pseudintermedius: A Preliminary Study of Four Clinical Strains.

Authors:  Francesca Paola Nocera; Giuseppe Iovane; Luisa De Martino; Bruce E Holbein
Journal:  Pathogens       Date:  2022-06-07

6.  The SCCmec Types and Antimicrobial Resistance among Methicillin-Resistant Staphylococcus Species Isolated from Dogs with Superficial Pyoderma.

Authors:  Yuttana Chanayat; Areerath Akatvipat; Jeff B Bender; Veerasak Punyapornwithaya; Tongkorn Meeyam; Usanee Anukool; Duangporn Pichpol
Journal:  Vet Sci       Date:  2021-05-13

7.  On Gram-Positive- and Gram-Negative-Bacteria-Associated Canine and Feline Skin Infections: A 4-Year Retrospective Study of the University Veterinary Microbiology Diagnostic Laboratory of Naples, Italy.

Authors:  Francesca Paola Nocera; Monica Ambrosio; Filomena Fiorito; Laura Cortese; Luisa De Martino
Journal:  Animals (Basel)       Date:  2021-05-29       Impact factor: 2.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.